Table 5. Summary performance of clinicians in the management of SAM (group A&B) among children aged 6 to 59 months admitted to CIN hospitals1 between December 2013 and November 2016.
| Management step | Proportion (%) of children eligible (pooled hospital data) |
Proportion (%) with indicator achieved (pooled hospital data) |
Median Hospital performance (%) |
Range for hospital performance (%) |
|---|---|---|---|---|
| 2Step 1: 10% dextrose prescribed | 644/4086 (15.8) | 67/644 (10.4) | 17.3 | (2.7,49.0) |
| Step 2: Axillary temperature | 4086/4086 (100) | 3775/4086 (92.4) | 91.5 | 69.3,99.4) |
| Step 3 A: ReSoMal prescribed | 1266/ 2093 (60.5) | 439/1266 (34.7) | 31.3 | (3.0,56.7) |
| 3Step 3 B: Blood transfusion | 191/4086 (4.7) | 68/191 (35.6) | 41.7 | (6.3,77.8) |
| Step 5 Antibiotics prescribed | 3345/4086 (81.9) | 2967/3345 (88.7) | 88.9 | (66.9,97.3) |
| Step 7 A: F75 prescribed | 3892/4086 (95.3) | 2027/3892 (52.1) | 51.5 | (19.1,76.2) |
| Step 7 B: Correct F75 dose | 3892/4086 (95.3) | 946/3892 (24.3) | 23.5 | (10.6,38.0) |
1Analysis restricted to SAM subgroups A and B
2 Computation of median and range in management steps 1 restricted to 8 hospitals with at least 5 hypoglycaemia cases per hospital
3Computation of median and range in management steps 3B restricted to 11 hospitals with at least 5 severe pallor cases